REPORT ID 4822

EMEA (Europe, Middle East and Africa) Megestrol Market Report 2017

Publish Date
19-Dec-17
Pages
119
Format
Electronic (PDF)

In this report, the EMEA Megestrol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Megestrol for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Megestrol market competition by top manufacturers/players, with Megestrol sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Sandoz
    GSK
    Mayne Pharma Inc
    Novartis
    Mylan
    Bristol Myers Squibb
    Abnova
    Abbott
    Takeda
    Guccess

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Injection
    Freeze-Dried Powder

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Megestrol Market Report 2017
1 Megestrol Overview
    1.1 Product Overview and Scope of Megestrol
    1.2 Classification of Megestrol
        1.2.1 EMEA Megestrol Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Megestrol Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Injection
        1.2.4 Freeze-Dried Powder
    1.3 EMEA Megestrol Market by Application/End Users
        1.3.1 EMEA Megestrol Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 EMEA Megestrol Market by Region
        1.4.1 EMEA Megestrol Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Megestrol (2012-2022)
        1.5.1 EMEA Megestrol Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Megestrol Revenue and Growth Rate (2012-2022)

2 EMEA Megestrol Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Megestrol Market Competition by Players/Manufacturers
        2.1.1 EMEA Megestrol Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Megestrol Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Megestrol Sale Price by Players (2012-2017)
    2.2 EMEA Megestrol (Volume and Value) by Type/Product Category
        2.2.1 EMEA Megestrol Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Megestrol Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Megestrol Sale Price by Type (2012-2017)
    2.3 EMEA Megestrol (Volume) by Application
    2.4 EMEA Megestrol (Volume and Value) by Region
        2.4.1 EMEA Megestrol Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Megestrol Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Megestrol Sales Price by Region (2012-2017)

3 Europe Megestrol (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Megestrol Sales and Value (2012-2017)
        3.1.1 Europe Megestrol Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Megestrol Revenue and Growth Rate (2012-2017)
    3.2 Europe Megestrol Sales and Market Share by Type
    3.3 Europe Megestrol Sales and Market Share by Application
    3.4 Europe Megestrol Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Megestrol Sales Volume by Countries (2012-2017)
        3.4.2 Europe Megestrol Revenue by Countries (2012-2017)
        3.4.3 Germany Megestrol Sales and Growth Rate (2012-2017)
        3.4.4 France Megestrol Sales and Growth Rate (2012-2017)
        3.4.5 UK Megestrol Sales and Growth Rate (2012-2017)
        3.4.6 Russia Megestrol Sales and Growth Rate (2012-2017)
        3.4.7 Italy Megestrol Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Megestrol Sales and Growth Rate (2012-2017)

4 Middle East Megestrol (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Megestrol Sales and Value (2012-2017)
        4.1.1 Middle East Megestrol Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Megestrol Revenue and Growth Rate (2012-2017)
    4.2 Middle East Megestrol Sales and Market Share by Type
    4.3 Middle East Megestrol Sales and Market Share by Application
    4.4 Middle East Megestrol Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Megestrol Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Megestrol Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Megestrol Sales and Growth Rate (2012-2017)
        4.4.4 Israel Megestrol Sales and Growth Rate (2012-2017)
        4.4.5 UAE Megestrol Sales and Growth Rate (2012-2017)
        4.4.6 Iran Megestrol Sales and Growth Rate (2012-2017)

5 Africa Megestrol (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Megestrol Sales and Value (2012-2017)
        5.1.1 Africa Megestrol Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Megestrol Revenue and Growth Rate (2012-2017)
    5.2 Africa Megestrol Sales and Market Share by Type
    5.3 Africa Megestrol Sales and Market Share by Application
    5.4 Africa Megestrol Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Megestrol Sales Volume by Countries (2012-2017)
        5.4.2 Africa Megestrol Revenue by Countries (2012-2017)
        5.4.3 South Africa Megestrol Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Megestrol Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Megestrol Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Megestrol Sales and Growth Rate (2012-2017)

6 EMEA Megestrol Manufacturers/Players Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Megestrol Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sandoz
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Megestrol Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sandoz Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GSK
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Megestrol Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GSK Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Mayne Pharma Inc
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Megestrol Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Mayne Pharma Inc Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Novartis
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Megestrol Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Novartis Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Mylan
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Megestrol Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Mylan Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Bristol Myers Squibb
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Megestrol Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Bristol Myers Squibb Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Abnova
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Megestrol Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Abnova Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Abbott
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Megestrol Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Abbott Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Takeda
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Megestrol Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Takeda Megestrol Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Guccess

7 Megestrol Manufacturing Cost Analysis
    7.1 Megestrol Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Megestrol

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Megestrol Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Megestrol Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Megestrol Market Forecast (2017-2022)
    11.1 EMEA Megestrol Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Megestrol Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Megestrol Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Megestrol Price and Trend Forecast (2017-2022)
    11.2 EMEA Megestrol Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Megestrol Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Megestrol Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Megestrol Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Megestrol Sales Forecast by Type (2017-2022)
    11.7 EMEA Megestrol Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer